Antazoline sulfate
| Status | Commercial |
| Development phase | |
| Therapeutic cat. | Other |
| Polymorphic form | |
| CAS No. | 24359-81-7 |
| Reference Product | |
| Injectable Form | |
| EU DMF readiness |  |
| CEP | |
| CHINESE DMF | |
| JAPANESE DMF | |
| KOREAN DMF | |
| CANADIAN DMF | |
| CADIFA | |
| US DMF readiness | |
| OEB No. | |
| Samples |
Drug description
Polpharma API
- Long experience in in-house commercial manufacturing
- In house production of the whole product family (Antazolines)
- No risk of nitrosoamine presence
- All intermediates produced in-house
